Teniposide (Intravenous Route)

3 imperatives to transform health care in America. You're invited to watch it live

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Teniposide (Intravenous Route)

Drug Information provided by: Micromedex

US Brand Names

  • Vumon

Description

Teniposide injection is used in combination with other medicines to treat acute lymphoblastic leukemia (ALL).

Teniposide belongs to the group of medicines known as antineoplastic agents. It interferes with the growth of the cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by teniposide, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, like hair loss, may not be serious but may cause concern. Some effects may not occur until months or years after the medicine is used.

Before you begin treatment with teniposide, you and your doctor should talk about the benefits of this medicine as well as the risks of using it.

This medicine is to be administered only by or under the immediate supervision of your doctor.

Before Using
DR601307 Portions of this document last updated: Dec. 1, 2011

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger